AZN Capital Corp News - AZN

AstraZeneca Calls on All Americans to Join US AGAINST ATHERO to Fight the Nation's Number One Killer

2009 Artery Explorer Tour Kicks Off This Month, Urging People Across the Country to Take Action Against Atherosclerosis WILMINGTON, Del., March...

Video: Astrazeneca Calls on All Americans to Join US AGAINST ATHERO to Fight the Nation's Number One Killer

2009 Artery Explorer Tour Kicks Off This Month, Urging People Across the Country to Take Action Against Atherosclerosis WILMINGTON, Del., March 24...

AstraZeneca Calls on All Americans to Join US AGAINST ATHERO to Fight the Nation's Number One Killer

2009 Artery Explorer Tour Kicks Off This Month, Urging People Across the Country to Take Action Against Atherosclerosis WILMINGTON, Del., March...

FDA Approves SYMBICORT(R) for Chronic Obstructive Pulmonary Disease (COPD)

SYMBICORT provides a new, fast-acting(1) combination treatment option for millions of Americans with debilitating lung disease WILMINGTON, Del...

AstraZeneca Announces SEROQUEL XR is Now Available to Treat Bipolar Depression

SEROQUEL XR is Now Approved to Treat the Depressive, Manic, and Mixed Episodes of Bipolar Disorder WILMINGTON, Del., Feb. 23...

AstraZeneca Helped More Than 440,000 Patients Save $612 Million on Medicines in 2008

Patients filled 2.7 million prescriptions through AZ&Me(TM) Prescription Savings Programs WILMINGTON, Del., Feb. 10 /PRNewswire-FirstCall/...

AstraZeneca Licenses Novel Antidepressant Compounds Discovered by Mayo Clinic and Virginia Tech Collaboration

Agreement includes research collaboration to generate follow-up TRI compounds WILMINGTON, Del., Feb. 9 /PRNewswire-FirstCall/ -- AstraZeneca...

AstraZeneca Submits sNDA for NEXIUM(R) for the Short-Term Treatment of GERD in Infants 0 to 1 Year Old

-Filing also includes age appropriate formulation of 2.5 mg and 5 mg strengths of NEXIUM for Delayed-Release Oral Suspension- WILMINGTON, Del...

AstraZeneca Settles US Pulmicort Respules Patent Litigation with Teva

WILMINGTON, Del., Nov. 25 /PRNewswire-FirstCall/ -- AstraZeneca today announced it has entered into a settlement agreement in its Pulmicort...

Pivotal Data Showed SYMBICORT(R) Improved Lung Function in Adults with COPD

Data also found SYMBICORT opened airways in less than 15 minutes WILMINGTON, Del., Oct. 29 /PRNewswire-FirstCall/ -- Data presented today from...

US Court Denies Teva's Motion for Summary Judgment in PULMICORT RESPULES(R) Patent Litigation

WILMINGTON, Del., Sept. 23 /PRNewswire-FirstCall/ -- AstraZeneca today announced that the US District Court for the District of New Jersey has...

AstraZeneca Receives Six Months Pediatric Exclusivity for CASODEX(R) (bicalutamide) from the FDA

WILMINGTON, Del., Sept. 22 /PRNewswire-FirstCall/ -- AstraZeneca today announced that the United States Food and Drug Administration (FDA) has...

Newly Released Data on Onset of Effect and Patient Perception With SYMBICORT in Adults With Asthma

WILMINGTON, Del., Sept. 10 /PRNewswire-FirstCall/ -- Newly released results from two previously published studies demonstrated patients...

TSX Venture Exchange Daily Bulletins for August 22, 2008

VANCOUVER, BRITISH COLUMBIA--(Marketwire - Aug. 22, 2008) - 08/08/22 - TSX Venture Exchange Daily Bulletins TSX VENTURE COMPANIES ABBASTAR...

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

AZN Capital Corp (AZN)

Professional-Grade Tools, for Individual Investors.

AZN News

AstraZeneca Calls on All Americans to Join US AGAINST ATHERO to Fight the Nation's Number One Killer

Video: Astrazeneca Calls on All Americans to Join US AGAINST ATHERO to Fight the Nation's Number One Killer

AstraZeneca Calls on All Americans to Join US AGAINST ATHERO to Fight the Nation's Number One Killer

FDA Approves SYMBICORT(R) for Chronic Obstructive Pulmonary Disease (COPD)

AstraZeneca Announces SEROQUEL XR is Now Available to Treat Bipolar Depression

AstraZeneca Helped More Than 440,000 Patients Save $612 Million on Medicines in 2008

AstraZeneca Licenses Novel Antidepressant Compounds Discovered by Mayo Clinic and Virginia Tech Collaboration

AstraZeneca Submits sNDA for NEXIUM(R) for the Short-Term Treatment of GERD in Infants 0 to 1 Year Old

AstraZeneca Settles US Pulmicort Respules Patent Litigation with Teva

Pivotal Data Showed SYMBICORT(R) Improved Lung Function in Adults with COPD

US Court Denies Teva's Motion for Summary Judgment in PULMICORT RESPULES(R) Patent Litigation

AstraZeneca Receives Six Months Pediatric Exclusivity for CASODEX(R) (bicalutamide) from the FDA

Newly Released Data on Onset of Effect and Patient Perception With SYMBICORT in Adults With Asthma

TSX Venture Exchange Daily Bulletins for August 22, 2008

AZN Discussion

Your Recent History

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

AZN Capital Corp (AZN) News

AZN Capital Corp (AZN)

Professional-Grade Tools, for Individual Investors.

AZN News

AstraZeneca Calls on All Americans to Join US AGAINST ATHERO to Fight the Nation's Number One Killer

Video: Astrazeneca Calls on All Americans to Join US AGAINST ATHERO to Fight the Nation's Number One Killer

AstraZeneca Calls on All Americans to Join US AGAINST ATHERO to Fight the Nation's Number One Killer

FDA Approves SYMBICORT(R) for Chronic Obstructive Pulmonary Disease (COPD)

AstraZeneca Announces SEROQUEL XR is Now Available to Treat Bipolar Depression

AstraZeneca Helped More Than 440,000 Patients Save $612 Million on Medicines in 2008

AstraZeneca Licenses Novel Antidepressant Compounds Discovered by Mayo Clinic and Virginia Tech Collaboration

AstraZeneca Submits sNDA for NEXIUM(R) for the Short-Term Treatment of GERD in Infants 0 to 1 Year Old

AstraZeneca Settles US Pulmicort Respules Patent Litigation with Teva

Pivotal Data Showed SYMBICORT(R) Improved Lung Function in Adults with COPD

US Court Denies Teva's Motion for Summary Judgment in PULMICORT RESPULES(R) Patent Litigation

AstraZeneca Receives Six Months Pediatric Exclusivity for CASODEX(R) (bicalutamide) from the FDA

Newly Released Data on Onset of Effect and Patient Perception With SYMBICORT in Adults With Asthma

TSX Venture Exchange Daily Bulletins for August 22, 2008

AZN Discussion

Your Recent History